Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant
- PMID: 24458202
- PMCID: PMC3983638
- DOI: 10.1038/eye.2013.314
Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant
Abstract
Purpose: Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening.
Methods: A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat's-like exudative vitreoretinopathy and treatment-resistant cystoid macular oedema.
Results: A reduction in the macular thickening following a single injection of Ozurdex.
Conclusion: We present our experience in successful treatment of refractory macular oedema with intravitreal injection of dexamethasone implant resulting in clinically significant resolution of macular thickening.
Figures
Similar articles
-
MICROSTRUCTURAL CHANGES IN CYSTOID MACULAR EDEMA IN RETINITIS PIGMENTOSA AFTER INTRAVITREAL DEXAMETHASONE IMPLANT INJECTION.Retina. 2021 Apr 1;41(4):852-860. doi: 10.1097/IAE.0000000000002944. Retina. 2021. PMID: 32796442
-
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa.J Ocul Pharmacol Ther. 2020 Apr;36(3):190-197. doi: 10.1089/jop.2018.0153. Epub 2019 Dec 30. J Ocul Pharmacol Ther. 2020. PMID: 31886707 Clinical Trial.
-
[Intravitreal implantation of Ozurdex® chronic delivery system for management of macular edema related to retinitis pigmentosa: case report].Arq Bras Oftalmol. 2013 Nov-Dec;76(6):377-9. doi: 10.1590/s0004-27492013000600013. Arq Bras Oftalmol. 2013. PMID: 24510088 Portuguese.
-
The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):160-4. doi: 10.3928/23258160-20140131-03. Epub 2014 Feb 7. Ophthalmic Surg Lasers Imaging Retina. 2014. PMID: 24506098 Review.
-
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review.BMC Ophthalmol. 2018 Dec 6;18(1):310. doi: 10.1186/s12886-018-0985-x. BMC Ophthalmol. 2018. PMID: 30522457 Free PMC article. Review.
Cited by
-
The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications.Front Cell Dev Biol. 2023 Apr 13;11:1177711. doi: 10.3389/fcell.2023.1177711. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37123408 Free PMC article.
-
Multimodal treatment of Coats-like exudative vitreoretinopathy in Goldmann-Favre syndrome.Am J Ophthalmol Case Rep. 2022 Jan 29;25:101362. doi: 10.1016/j.ajoc.2022.101362. eCollection 2022 Mar. Am J Ophthalmol Case Rep. 2022. PMID: 35243140 Free PMC article.
-
Coats-like exudative vitreoretinopathy (CLEVER) in CEP290 inherited retinal degeneration.BMJ Case Rep. 2022 Feb 15;15(2):e247229. doi: 10.1136/bcr-2021-247229. BMJ Case Rep. 2022. PMID: 35168937 Free PMC article. No abstract available.
-
Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):159-179. doi: 10.1097/APO.0000000000000290. Asia Pac J Ophthalmol (Phila). 2020. PMID: 32511120 Free PMC article. Review.
-
Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.Int Ophthalmol. 2020 Mar;40(3):677-687. doi: 10.1007/s10792-019-01228-z. Epub 2019 Nov 26. Int Ophthalmol. 2020. PMID: 31773389
References
-
- Kajiwara Y. Ocular complications of retinitis pigmentosa. Association with Coat's syndrome. Jpn J Clin Ophthalmol. 1980;34:947–955.
-
- Khan JA, Ide CH, Strickland MP. Coat's-type retinitis pigmentosa. Surv Ophthalmol. 1988;32 (5:317–332. - PubMed
-
- Ramasubramanian A, Shields CL. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol. 2012;96 (3:356–359. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical